Explore the details of the Theravance Biopharma R&D Ip, Llc V. Eugia Pharma Specialties Ltd. case under case number 1:23-cv-00926 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-00926
Filing Date
Feb 16, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
MEDICHEM USA, LLC -
LUPIN LTD. -
LIFESTAR PHARMA LLC -
MYLAN IRELAND LIMITED -
INTAS PHARMACEUTICALS LTD. -
THERAVANCE BIOPHARMA IRELAND LIMITED -
CIPLA LIMITED -
MANKIND PHARMA LTD. -
ACCORD HEALTHCARE INC. -
TEVA PHARMACEUTICAL INDUSTRIES LTD. -
AUROBINDO PHARMA USA, INC. -
EUGIA PHARMA SPECIALITIES LTD. -
ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 9, 2025OPINION. Signed by Judge Karen M. Williams on 6/9/2025. (sms2)PACER Document
Aug 6, 2025OPINION. Signed by Judge Karen M. Williams on 8/6/25. (nar)PACER Document